Tag: Biopharmaceutical

Top News Stories November 29 2017

29/11/2017

The day’s top news stories from stocks on the GuerillaStockTrading watch list. Apple Inc. (AAPL) (11/29) UPDATE 1-Apple to audit development processes after Mac bug discovered – Nov 29 (Reuters) – Apple Inc said on Wednesday it would review its software development process a day after a researcher discovered a bug in a new Read More »

Celgene stock shows a consolidation or basing pattern.

Celgene Stock Now Oversold After Miss and Stopped REVOLVE Trial

20/11/2017

Celgene stock has formed a great looking consolidation or basing pattern after dropping -35% on news that was not too bad. I think we have a great bottom feeder play here.

Sarepta Therapeutics stock in strong uptrend.

Sarepta Therapeutics In Strong Uptrend From Exondys 51

19/11/2017

Sarepta Therapeutics could get European marketing approval for Exondys 51 at any time which will boost sales. Meanwhile, the company has great growth and is advancing other drugs through its pipeline.

BeiGene stock shows exploding large players volume.

BeiGene Stock Exploding Large Players Volume On Candle Over Candle

16/11/2017

BeiGene stock has large players volume exploding higher. The company reported eye-popping earnings and revenue beats this week.

Top News Stories November 14 2017

14/11/2017

The day’s top news stories from stocks on the GuerillaStockTrading watch list. Apple Inc. (AAPL) (11/14) Foxconn’s third quarter profit slides below estimates after iPhone X production hurdles – TAIPEI (Reuters) – Taiwan’s Foxconn , the world’s largest contract electronics manufacturer, saw quarterly profit slide 39 percent – a result far Read More »

Deciphera Pharmaceuticals stock has pulled back to the IPO price.

Deciphera Pharmaceuticals Quiet Period Ended This Week

10/11/2017

Deciphera Pharmaceuticals will likely be pumped by the IPO underwriters soon now that the quiet period has ended.

Intercept Pharmaceuticals stock chart shows rising large players volume.

Intercept Pharmaceuticals Rising Large Players Volume

5/11/2017

Intercept Pharmaceuticals stock sold off on an FDA warning letter at the end of the quarter. Since, large players volume has been rising while the stock has formed a basing pattern.

Waiting for a consolidation in Verastem Inc stock.

Verastem Price Target Set 364 Percent Higher By Cantor Fitzgerald

31/10/2017

SUBSCRIBE OR SIGN IN

Incyte Corporation stock chart shows rising large players volume while price consolidates in an Ascending Triangle pattern.

Incyte Corporation Rising Large Players Volume in Ascending Triangle

30/10/2017

SUBSCRIBE OR SIGN IN

Sorrento Therapeutics stock has done a 61.8 percent Fibonacci retracement.

Sorrento Therapeutics Inc Bounce Off 61.8 Percent Retracement

22/10/2017

SUBSCRIBE OR SIGN IN